glutathione pathway to triple negative cancer Metabolic interplay between exogenous cystine and glutamine dependence in triple-negative breast Targeting Glutathione Metabolism: Partner in
Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Glutathione Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor Positive Triple Negative Breast Cancer ACS Nano Frontiers Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple negative breast cancer Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect
Pay in 4 interest-free payments of $7.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



